Selected article for: "present study and study examine"
Author: Todd, C. G.; Millman, S. T.; McKnight, D. R.; Duffield, T. F.; Leslie, K. E.
Title: Nonsteroidal anti-inflammatory drug therapy for neonatal calf diarrhea complex: Effects on calf performance
  • Document date: 2010_6_23
    • ID: 326huu05_3
    Snippet: It has been reported that altering the activity of cyclooxygenase-2 (COX-2) may be a way of mitigating sickness behavior and enhancing disease recovery (Lugarini et al., 2002) . Meloxicam (MEL) is a nonsteroidal anti-inflammatory drug (NSAID) that preferentially inhibits COX-2 and has a half-life of approximately 26 h in bovine plasma (European Agency for the Evaluation of Medicinal Products, 2007) . A field study reported that MEL administration.....
    Document: It has been reported that altering the activity of cyclooxygenase-2 (COX-2) may be a way of mitigating sickness behavior and enhancing disease recovery (Lugarini et al., 2002) . Meloxicam (MEL) is a nonsteroidal anti-inflammatory drug (NSAID) that preferentially inhibits COX-2 and has a half-life of approximately 26 h in bovine plasma (European Agency for the Evaluation of Medicinal Products, 2007) . A field study reported that MEL administration to calves with diarrhea resulted in improvements in clinical variables (Philipp et al., 2003) . The objective of the present study was to examine the efficacy of MEL as a supportive therapy for calves with neonatal calf diarrhea complex. The hypothesis underlying this study was that NSAID therapy at the onset of diarrhea would attenuate sickness behavior, as well as alleviate malaise and gastrointestinal discomfort, thereby encouraging calves to maintain a strong appetite during sickness and supporting calf performance.

    Search related documents:
    Co phrase search for related documents
    • gastrointestinal discomfort and present study: 1, 2
    • MEL administration and neonatal calf diarrhea complex: 1
    • MEL administration and sickness behavior: 1
    • MEL efficacy and neonatal calf diarrhea complex: 1
    • MEL efficacy and supportive therapy: 1
    • MEL efficacy examine and neonatal calf diarrhea complex: 1
    • MEL efficacy examine and supportive therapy: 1
    • neonatal calf diarrhea complex and NSAID therapy: 1
    • neonatal calf diarrhea complex and sickness behavior: 1, 2
    • neonatal calf diarrhea complex and strong appetite: 1
    • neonatal calf diarrhea complex and supportive therapy: 1, 2
    • neonatal calf diarrhea complex calf and supportive therapy: 1
    • nonsteroidal NSAID anti inflammatory drug and NSAID anti inflammatory drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • nonsteroidal NSAID anti inflammatory drug and NSAID therapy: 1, 2, 3, 4, 5
    • nonsteroidal NSAID anti inflammatory drug and present study: 1
    • nonsteroidal NSAID anti inflammatory drug and supportive therapy: 1
    • NSAID anti inflammatory drug and present study: 1, 2
    • NSAID anti inflammatory drug and supportive therapy: 1
    • NSAID therapy and supportive therapy: 1